Dow Up 0.76% Nasdaq Up 0.69%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
4.72 Up 0.11(2.39%) 4:00PM EDT
Prev Close:4.61
Open:4.62
Bid:N/A
Ask:4.78 x 4000
1y Target Est:8.33
Beta:2.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.50 - 4.73
52wk Range:3.10 - 7.45
Volume:763,999
Avg Vol (3m):902,441
Market Cap:328.30M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 2.39%328.30M
DNDNDown 0.96%160.09M
NKTRDown 0.75%1.67B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):44.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-1.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback